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exclusively relies on the malonyl-CoA bypass, was detri-
mental for growth and farnesene production. The presented 
results indicate that the overall functionality of the bypass 
was limited by the efficiency of acetoacetyl-CoA synthase 
(nphT7). Besides modulation of the expression level, which 
could be used as a means to partially restore the pheno-
type, nphT7 from Streptomyces glaucescens showed clearly 
higher efficiency compared to Streptomyces sp. strain 
CL190.
Keywords Isoprenoids · Mevalonate pathway · Biofuels · 
Yeast · Metabolic engineering
Introduction
The mevalonate pathway is of crucial importance for Sac-
charomyces cerevisiae as it is used for synthesis of sterols, 
ubiquinone and dolichols. Besides, the pathway has been 
exploited for the production of sesquiterpenes, which have 
different applications within the chemical industry and can 
be provided from microbial fermentation using renewable 
carbon sources [18]. In the first reaction of the pathway, 
acetoacetyl-CoA thiolase (encoded by ERG10) catalyzes 
the reversible non-decarboxylative Claisen condensation 
of two acetyl-CoA molecules to produce acetoacetyl-CoA 
(Fig. 1). Activity of this enzyme was shown to be regu-
lated by intracellular sterol levels [7, 9], whereas loss of 
ERG10 was reported to result in mevalonate auxotrophy 
[10]. However, the reaction is thermodynamically unfa-
vorable (ΔG0′ ≈ 7 kcal/mol [14, 34]), imposing con-
straints on the concentrations of acetyl-CoA to enable 
acetoacetyl-CoA synthesis. Recently, nphT7 present in the 
mevalonate pathway gene cluster in Streptomyces sp. strain 
CL190 was identified to encode a novel acetoacetyl-CoA 
Abstract Efficient production of sesquiterpenes in Sac-
charomyces cerevisiae requires a high flux through the 
mevalonate pathway. To achieve this, the supply of acetyl-
CoA plays a crucial role, partially because nine moles of 
acetyl-CoA are necessary to produce one mole of farnesyl 
diphosphate, but also to overcome the thermodynamic con-
straint imposed on the first reaction, in which acetoacetyl-
CoA is produced from two moles of acetyl-CoA by ace-
toacetyl-CoA thiolase. Recently, a novel acetoacetyl-CoA 
synthase (nphT7) has been identified from Streptomyces sp. 
strain CL190, which catalyzes the irreversible condensa-
tion of malonyl-CoA and acetyl-CoA to acetoacetyl-CoA 
and, therefore, represents a potential target to increase the 
flux through the mevalonate pathway. This study inves-
tigates the effect of acetoacetyl-CoA synthase on growth 
as well as the production of farnesene and compares dif-
ferent homologs regarding their efficiency. While plasmid-
based expression of nphT7 did not improve final farnesene 
titers, the construction of an alternative pathway, which 
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synthase [21], which catalyzes the energetically more 
favorable (estimated ΔG0′ = −0.9 kcal/mol [34]) decar-
boxylative condensation of malonyl-CoA and acetyl-CoA 
to acetoacetyl-CoA. The enzyme was reported to produce 
acetoacetyl-CoA also from malonyl-CoA as sole substrate, 
but most importantly, it did not display thiolysis activity 
in vitro [21]. For this reason, it was suggested to be ideal 
for the production of butanol, polyhydroxyalkanoates and 
isoprenoids. In S. cerevisiae, the enzyme successfully sup-
ported butanol production and also displayed similar enzy-
matic activity in vitro in comparison to the endogenous 
acetoacetyl-CoA thiolase [29]. In contrast, Menon et al. 
reported 6.2-fold higher titers of butanol produced from 
Escherichia coli using the endogenous acetoacetyl-CoA 
thiolase (atoB) over nphT7 for supply of acetoacetyl-CoA 
[19]. Furthermore, acetoacetyl-CoA synthase has also been 
used for the production of butanol in Synechococcus elon-
gatus [14], for the production of propane in E. coli [19] 
and for poly-3-hydroxybutyrate production in mesophyl-
lic cells of sugarcane [17]. The objective of this study was 
to investigate the effect of the acetoacetyl-CoA synthase 
on the production of sesquiterpenes in S. cerevisiae using 
farnesene as an example. Farnesene is directly produced 
from farnesyl diphosphate (FPP) using farnesene synthase 
and its production requires 9 mol·mol−1 of acetyl-CoA. 
Efficient conversion of acetyl-CoA to acetoacetyl-CoA 
using nphT7 for increased flux through the pathway repre-
sents a potential target to improve the production of these 
compounds. Since the enzyme requires malonyl-CoA as 
extender substrate, overexpression of the modified acetyl-
CoA carboxylase (ACC1**), which displayed enhanced 
activity, was used additionally to promote the influx from 
malonyl-CoA into the pathway [30]. As increased levels of 
acetoacetyl-CoA could potentially stimulate acetoacetyl-
CoA thiolysis and result in a futile cycle, the endogenous 
ERG10 was replaced by nphT7 as an alternative approach 
to produce acetoacetyl-CoA exclusively from malonyl-
CoA and to compare both pathways regarding growth and 
product formation. Since carboxylation of acetyl-CoA to 
malonyl-CoA requires additional ATP, which could reduce 
the product yield, this route becomes less efficient with 
respect to free energy conservation (Fig. 1). However, 
energy released from ATP hydrolysis (ΔG0′ < −7 kcal/
mol) could be utilized successfully to drive biochemical 
reactions for butanol production, by compensating for the 
required energy for acetoacetyl-CoA synthesis via conden-
sation of two molecules of acetyl-CoA [14].
Materials and methods
Plasmid and strain construction
The nphT7 gene from Streptomyces sp. strain CL190 
(nphT7SCL) as well as the homologous genes from Strepto-
myces glaucescens, Streptomyces afghaniensis, Streptomy-
ces lactacystinaeus and Nocardia brasiliensis were codon 
optimized and synthesized by GenScript (Piscataway, 
NJ, USA). nphT7SCL was amplified by PCR and cloned 
into pSP-GM1 using restriction enzymes NotI and PacI, 
resulting in plasmid pIST07. For construction of plasmids 
pIST12-16, the truncated HXT7 promoter PtHXT7 and HIS5 
terminator THIS5 were amplified from S. cerevisiae CEN.
PK113-5D and fused to each of the nphT7 genes by PCR. 
The constructed cassettes were then amplified by PCR to 
generate the complementary overhangs for insertion into 
plasmid pIST05 using CPEC [25]. An overview of all plas-
mids used in this study is provided by Table 1. Primers 
used for plasmid construction are listed in Table S1. Chro-
mosomal integration of ACC1** [30] into site X-2 was 
achieved using plasmid pMG96 (provided by Dr. Michael 
Gossing, Chalmers University of Technology, Sweden), a 
derivative of vector pCfB353 [11]. Substitutions of ERG10 
by nphT7 from Streptomyces sp. strain CL190 were per-
formed in strains RF14 and IMX581 using CRISPR/
Cas9 [15]. IMX581 and the CRISPR plasmid backbone 
(pMEL10) were obtained from EUROSCARF (Frankfurt, 
Germany). The guide RNA targeting the ERG10 locus was 
Fig. 1  Simplified illustration of the mevalonate pathway in S. cerevi-
siae, which is utilized for sterol synthesis. Besides, farnesyl diphos-
phate (FPP) can be converted to farnesene. In the first reaction of the 
pathway, acetoacetyl-CoA thiolase (ERG10) produces acetoacetyl-
CoA from two molecules of acetyl-CoA. Alternatively, acetoacetyl-
CoA can be produced from malonyl-CoA using acetoacetyl-CoA syn-
thase (nphT7) identified from Streptomyces sp. strain CL190, which 
was investigated in this study
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designed using the Yeastriction webtool (http://yeastriction.
tnw.tudelft.nl/). The nphT7SCL gene was amplified from 
pIST07 by PCR and used as repair fragment. Simultaneous 
transformation with pMEL10, the ERG10 specific guide 
RNA and the nphT7SCL repair fragment resulted in the 
in vivo assembly of the plasmid, mediating a double-strand 
cut in the ERG10 gene by the Cas9 nuclease. The double-
strand break allowed integration of the nphT7SCL cassette 
by homologous recombination, ultimately resulting in 
strain SCIST17, 19 (nphT7 expression using endogenous 
promoter and terminator) and SCIST38 (nphT7SCL expres-
sion using PTEF1/TADH1). Replacing the endogenous FAS1 
promoter PFAS1 by PHXT1 for construction of strain SCIST41 
was performed as described previously [5]. Table 2 pro-
vides an overview of all strains used in this study, whereas 
primers used for construction of these strains are listed in 
Table S2. 
Growth medium
Saccharomyces cerevisiae strains with uracil auxotro-
phy were grown on YPD plates containing 20 g/L glu-
cose, 10 g/L yeast extract, 20 g/L peptone from casein and 
20 g/L agar. Plasmid carrying strains were grown on selec-
tive growth medium containing 6.9 g/L yeast nitrogen base 
w/o amino acids (Formedium, Hunstanton, UK), 0.77 g/L 
complete supplement mixture w/o uracil (Formedium), 
20 g/L glucose and 20 g/L agar. Shake flask cultivations 
were performed in minimal medium containing 30 g/L 
glucose, 7.5 g/L (NH4)2SO4, 14.4 g/L KH2PO4, 0.5 g/L 
MgSO4·7H2O, 2 mL/L trace element solution and 50 μL/L 
antifoam (Sigma-Aldrich, St. Louis, MO, USA). After ster-
ilization, vitamin solution was added at a concentration of 
1 mL/L. The batch phase medium during aerated bioreac-
tor cultivations contained 10 g/L glucose, 5 g/L (NH4)2SO4, 
3 g/L KH2PO4, 0.5 g/L MgSO4·7H2O, 1 mL/L trace ele-
ment solution, 50 μL/L antifoam and 1 mL/L vitamin 
solution. During the fed-batch phase, the feed medium was 
five times concentrated and contained glucose to a concen-
tration of 100 g/L. The composition of the trace element 
and vitamin solution has been reported by Verduyn et al. 
[33].
Shake flask cultivations
For cultivations in shake flasks, 5 mL of minimal medium 
were inoculated with a single colony from an agar plate 
with selective medium and incubated at 200 rpm and 30 °C 
for 48 h. Subsequently, the pre-culture was used to inocu-
late 18 mL of minimal medium in shake flasks without 
baffles and a total volume of 100 mL at an OD600 of 0.1. 
Finally, 2 mL of dodecane (≥99%, Reagent Plus, Sigma-
Aldrich) were added to a final concentration of 10% v/v 
to sequester farnesene during the cultivation. Shake flasks 
were incubated at 180 rpm and 30 °C for 72 h.
Bioreactor cultivations
For cultivation of S. cerevisiae strains in bioreactors, a sin-
gle colony from a plate with selective medium was used to 
inoculate 5 mL of minimal medium used for shake flask 
cultivations. After incubation at 200 rpm and 30 °C over-
night, the culture was transferred to a shake flask with 
45 mL of minimal medium and incubated at 180 rpm and 
30 °C for another 24 h. Subsequently, the culture was used 
to inoculate 400 mL of batch phase medium. Cultivations 
in bioreactors were performed using DasGip Parallel Bio-
reactor Systems for Microbiology (Eppendorf, Hamburg, 
Germany). The vessels were aerated at 30 L/h and homoge-
neous mixing was accomplished using a six-blade Rushton 
turbine at a stirring speed of 600 rpm. The temperature 
was adjusted to 30 °C and the pH was controlled at 5 using 
2 M HCl and 2 M KOH. Composition of the exhaust gas 
was monitored on-line using the DasGip GA4 gas analyzer 
(Eppendorf). Bioreactor cultivations were started in batch 
mode. After glucose and ethanol depletion, 80 mL of dode-
cane were added under aseptic conditions and the feed was 
initiated. To allow for exponential growth at μ = 0.08 h−1, 
the feed rate was set to ν(t) = 0.003·exp(0.08·t), with ν as 
the feed rate in L/h and t as feed time in h. In addition, the 
feed was stopped at values of the respiratory quotient (RQ) 
above one to avoid overflow metabolism [32].
BioLector cultivations
Growth curves were recorded using the BioLector (m2p-
labs, Baesweiler, Germany). For this purpose, a single col-
ony was picked from an agar plate with selective medium 
and used to inoculate 3 mL of minimal medium. After 48 h 
of incubation at 30 °C and 200 rpm, the culture was used 
Table 1  List of plasmids used in this study
Plasmid Description References
pSP-GM1 PTEF1-PPGK1 bidirectional promoter (2 μm, 
URA3)
[3]
pMEL10 gRNA-CAN1.Y (2 μm, URA3) [15]
pIST05 PPGK1-tHMG1, PTEF1-FarnSyn_Cj [32]
pMG96 PTEF1-ACC1** This study
pIST07 PTEF1- nphT7SCL This study
pIST12 pIST05, PtHXT7-nphT7SCL This study
pIST13 pIST05, PtHXT7-nphT7Sg This study
pIST14 pIST05, PtHXT7-nphT7Sa This study
pIST15 pIST05, PtHXT7-nphT7Sl This study
pIST16 pIST05, PtHXT7-nphT7Nb This study
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to inoculate 1 mL of minimal medium at an OD600 of 0.1. 
Subsequently, the culture was transferred into a 48-well 
microtiter plate (MTP-48-B FlowerPlate, m2p-labs) and 
incubated at 30 °C and 1200 rpm using the BioLector. The 
Table 2  List of strains used in this study
Name Relevant Genotype Plasmid References
CEN.PK113-5D MATa MAL2-8c SUC2 ura3-52 – P. Kötter, University of 
Frankfurt, Germany
SCIST05 MATa MAL2-8c SUC2 ura3-52 pIST05 [32]
IMX581 MATa MAL2-8c SUC2 ura3-52 can1Δ::cas9-natNT2 – [15]
SCIST15 MATa MAL2-8c SUC2 ura3-52 can1Δ::cas9-natNT2 pIST05 This study
RF14 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX can1Δ::cas9-natNT2 – This study
SCIST16 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX can1Δ::cas9-natNT2 pIST05 This study
SCIST17 MATa MAL2-8c SUC2 ura3-52 can1Δ::cas9-natNT2 erg10Δ::nphT7SCL – This study
SCIST18 MATa MAL2-8c SUC2 ura3-52 can1Δ::cas9-natNT2 erg10Δ:: nphT7SCL pIST05 This study
SCIST19 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
– This study
SCIST20 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
pIST05 This study
SCIST21 MATa MAL2-8c SUC2 ura3-52 pIST12 This study
SCIST22 MATa MAL2-8c SUC2 ura3-52 pIST13 This study
SCIST23 MATa MAL2-8c SUC2 ura3-52 pIST14 This study
SCIST24 MATa MAL2-8c SUC2 ura3-52 pIST15 This study
SCIST25 MATa MAL2-8c SUC2 ura3-52 pIST16 This study
SCIST26 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX – This study
SCIST27 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX pIST05 This study
SCIST28 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX pIST12 This study
SCIST29 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX pIST13 This study
SCIST30 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX pIST14 This study
SCIST31 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX pIST15 This study
SCIST32 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** PTEF1-kanMX pIST16 This study
SCIST33 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
pIST12 This study
SCIST34 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
pIST13 This study
SCIST35 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
pIST14 This study
SCIST36 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
pIST15 This study
SCIST37 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ:: 
nphT7SCL
pIST16 This study
SCIST38 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ::PTEF1-
nphT7SCL
– This study
SCIST39 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ::PTEF1-
nphT7SCL
pIST05 This study
SCIST40 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ::PTEF1-
nphT7SCL
pIST13 This study
SCIST41 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ::PTEF1-
nphT7SCL PTEF1-kanMX PFAS1Δ::PHXT1
– This study
SCIST43 MATa MAL2-8c SUC2 ura3-52 PTEF1-ACC1** can1Δ::cas9-natNT2 erg10Δ::PTEF1-
nphT7SCL PTEF1-kanMX PFAS1Δ::PHXT1
pIST13 This study
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optical density was measured on-line in 30 min intervals at 
a filter gain of 30.
Measurement of cell growth
A spectrophotometer (Genesis20, Thermo Fisher Scien-
tific, Waltham, MA, USA) was used to measure cell growth 
at the end of the shake flask cultivations. For cultivations 
in bioreactors, the biomass was measured by pipetting a 
5 mL sample onto a pre-weighted filter with a pore size of 
0.45 μm (Sartorius, Göttingen, Germany). The filter was 
rinsed with water, dried at 150 W for 15 min and kept in 
a desiccator until it was weighted again. Biomass concen-
trations are expressed as gram dry cell weight per volume 
(gDCW/L).
Quantification of extracellular metabolites
For the quantification of glucose and ethanol, samples 
were taken at the end of the shake flask and during the 
bioreactor cultivations. For this purpose, the biomass 
was removed by centrifugation at 4000 rpm for 3 min or 
by filtration using a 0.45 μm nylon filter (VWR Interna-
tional AB, Stockholm, Sweden). Sample analysis was per-
formed by HPLC using a Dionex Ultimate 3000 (Dionex, 
Sunnyvale, CA, USA) together with an Aminex HPX-87H 
column (300 × 7.8 mm, Bio-Rad Laboratories, Hercules, 
CA, USA) and a refractive index detector (512 μRIU). The 
column temperature was kept constant at 45 °C and 15 μL 
were injected into the mobile phase consisting of 5 mM 
H2SO4. The flow rate was set to 0.6 mL/min.
Quantification of farnesene
At the end of the cultivation, the dodecane overlay was har-
vested by centrifugation at 4000 rpm for 3 min. Similarly, 
samples were collected during cultivations in bioreactors. 
Analysis was performed using a Focus GC-FID (Thermo 
Fisher Scientific) equipped with a ZB-50 column (Phenom-
enex, Torrance, CA, USA) as described previously with 
minor modifications [31]. The initial temperature was held 
at 50 °C for 1.5 min and then increased to 170 °C at a rate 
of 15 °C/min. After keeping the temperature constant for 
another 1.5 min, it was raised at the same rate to 300 °C and 
held for 3.0 min. The inlet temperature was set to 250 °C 
and 2 μL sample were injected in splitless mode. The base 
temperature of the flame was set to 300 °C. Farnesene was 
quantified using external calibration with trans-β-farnesene 
as analytical standard (≥90%, Sigma Aldrich). Samples 
were diluted in hexane and patchoulol (≥99%, a kind gift 
from Firmenich, Geneva, Switzerland) was added as inter-
nal standard. Concentrations of farnesene are stated based 
on the volume of the aqueous phase of the medium (mg/
Laq).
Quantification of lipids
Samples for lipid analysis were taken at the end of the fed-
batch cultivations, after 15 h of feeding. For this purpose, 
5 mL of the cultivation broth were added to 20 mL of meth-
anol (Sigma-Aldrich), which was kept at −40 °C using a 
Huber CC-410 thermostat (Huber, Offenburg, Germany). 
Subsequently, the samples were centrifuged at 4000 rpm 
and −20 °C for 5 min. The supernatant was discarded and 
the cells were washed using 5 mL of methanol. After cen-
trifugation at 4000 rpm and −20 °C for 5 min, the biomass 
was freeze-dried using a Christ alpha 2–4 LSC (Christ 
Gefriertrocknungsanlagen, Osterode, Germany) and ana-
lyzed as described by Khoomrung et al. [13].
Results
Heterologous expression of different nphT7 homologs 
for farnesene production
Acetoacetyl-CoA synthase from Streptomyces sp. strain 
CL190 was identified to catalyze the irreversible decar-
boxylative condensation of malonyl-CoA and acetyl-
CoA to acetoacetyl-CoA and could hence improve the 
production of isoprenoids. To determine the effect of the 
enzyme on the production of sesquiterpenes, nphT7SCL 
was expressed from a multi-copy plasmid together with 
a farnesene synthase from Citrus junos (FarnSyn), which 
converts FPP to farnesene [16] and a truncated version 
of the HMG-CoA reductase (tHMG1), which reduces 
HMG-CoA to mevalonate, but lacks the NH2-terminal 
transmembrane domain [8, 24]. The structure of plas-
mid pIST12 is presented in Fig. S7 of the supplementary 
material. In addition, four homologous genes from other 
bacterial species, i.e. S. glaucescens, S. afghaniensis, S. 
lactacystinaeus and N. brasiliensis, were selected to iden-
tify differences regarding the efficiency of the enzymes. 
The first two genes encode for putative acetoacetyl-CoA 
synthases, while the latter two belong to the class of 
β-ketoacyl-ACP synthase (KAS) III enzymes, which con-
vert malonyl-ACP and acetyl-CoA to acetoacetyl-ACP. 
Although nphT7SCL is homologous to fabH (KASIII) 
from E. coli, also containing the highly conserved cata-
lytic triad at Cys115, His256 and Asn286, the enzyme did 
not show KASIII activity, presumably because it lacks an 
important arginine residue required for ACP binding [21]. 
On the contrary, KASIII enzymes from S. lactacystinaeus 
and N. brasiliensis share an AGGSR motif with the amino 
acid sequence of NphT7, which is not present in FabH 
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from E. coli, but was suggested to be involved in recogni-
tion of the CoA moiety [21]. Hence, these enzymes could 
potentially be able to accept malonyl-CoA as substrate. 
Multiple sequence alignment of the homologs showing 
the putative CoA binding motif and results of a BLAST 
of these homologs to NphT7 from Streptomyces sp. strain 
CL190 are presented in Fig. S1 and Table S3 of the sup-
plementary material. When S. cerevisiae strain CEN.
PK113-5D was transformed with plasmids pIST12-16 
and cultivated in shake flasks, expression of nphT7SCL 
from Streptomyces sp. strain CL190 did not improve pro-
duction of farnesene in comparison to strain SCIST05, 
which does not express an acetoacetyl-CoA synthase 
(Fig. 2a). In fact, final farnesene titers slightly decreased 
on average from 9.3 to 7.6 mg/Laq. Furthermore, no dif-
ference between the strains expressing the different 
homologs was observed as farnesene concentrations were 
almost equal with approximately 8 mg/Laq. Since the 
effect of the enzymes could be restricted by the supply 
of malonyl-CoA, which is a crucial intermediate in fatty 
acid synthesis, we aimed at increasing the availability of 
malonyl-CoA as extender substrate for the acetoacetyl-
CoA synthase. For this reason, plasmids pIST12-16 were 
also introduced into strain SCIST26, which carries a 
chromosomal integration of the mutated acetyl-CoA car-
boxylase (ACC1**) (Fig. 2b). Site mutations at Ser659 
and Ser1157 have been shown to reduce sensitivity to 
Snf1 mediated phosphorylation, which led to a substan-
tial increase in Acc1p activity [30]. However, even with 
the expression of ACC1** there was no improvement of 
farnesene production and no difference between the dif-
ferent homologs. Surprisingly, final farnesene titers were 
reduced overall to approximately 6 mg/Laq.
Evaluation of an alternative pathway for farnesene 
production
Overexpression of nphT7SCL did not result in improved 
production of farnesene. Promoted thiolysis of acetoacetyl-
CoA to acetyl-CoA due to increased levels of acetoacetyl-
CoA could explain these results. To confirm this observa-
tion, we aimed at providing acetoacetyl-CoA exclusively 
via the malonyl-CoA route, allowing for a comparison of 
the native and the modified pathway. Therefore, endog-
enous ERG10 was replaced in frame by nphT7SCL, leaving 
the ERG10 promoter and terminator. While the endogenous 
pathway is limited by thermodynamic constraints, the 
bypass via malonyl-CoA requires an additional reaction and 
increases the ATP demand of the pathway. Although ATP 
conservation plays a crucial role in metabolic engineering 
and an increased ATP demand is preferably avoided [6], 
ATP has recently been used as a driving force for the pro-
duction of butanol in S. elongatus PCC 7942 [14]. Substitu-
tion of ERG10 by nphT7SCL was performed in strains with 
and without ACC1** integration. Although the increased 
conversion of acetyl-CoA to malonyl-CoA using ACC1** 
by itself had a negative effect on production of farnesene 
(Fig. 2b), more flux towards malonyl-CoA might be benefi-
cial to support the pathway when ERG10 is removed. How-
ever, in both strains (SCIST18 and 20), the loss of ERG10 
resulted in a substantial decrease of final farnesene titers by 
more than 90%, whereas titers were slightly higher with-
out overexpression of ACC1** (Fig. 3a). Since both strains 
utilize the endogenous ERG10 promoter and terminator, 
these results indicate that the expression of nphT7SCL is 
not sufficient to fully compensate for the loss of ERG10. 
Variation of the promoter strength is commonly used to 
Fig. 2  Effect of heterologous acetoacetyl-CoA synthase on produc-
tion of farnesene in S. cerevisiae. Strains carry plasmids for expres-
sion of farnesene synthase, truncated HMG-CoA reductase and 
acetoacetyl-CoA synthase (nphT7) from different bacterial strains, 
without (a) and with (b) chromosomal integration of double mutant 
acetyl-CoA carboxylase (ACC1**). SCL—Streptomyces sp. strain 
CL190, Sg—S. glaucescens, Sa—S. afghaniensis, Sl—S. lactacysti-
naeus and Nb—N. brasiliensis. Bars represent average concentrations 
of farnesene with respect to the volume of aqueous medium of three 
biological replicates with standard deviation
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improve expression [1]. Likewise, the terminator sequence 
has been shown to alter expression by changing mRNA 
stability [4]. Hence, integration of the gene was also per-
formed using PTEF1 and TADH1 to enhance the transcript 
level (strain SCIST39). Although farnesene concentrations 
remained significantly lower compared to the reference 
(SCIST05), manipulation of the nphT7SCL expression level 
resulted in an almost fourfold increase of farnesene produc-
tion compared to SCIST20 (ACC1**, erg10Δ::nphT7SCL 
with pIST05) (Fig. 3a). To evaluate the selected homologs 
when acetoacetyl-CoA cannot be degraded by acetoacetyl-
CoA thiolase, plasmids pIST12-16 carrying the different 
nphT7SCL homologous genes, were introduced into strain 
SCIST19 (ACC1**, erg10Δ::nphT7SCL). Similar to vary-
ing the promoter strength of the chromosomally integrated 
nphT7 from Streptomyces sp. strain CL190, a higher copy 
number (and using a strong promoter) also led to higher 
final farnesene titers (SCIST33, Fig. 3b). Furthermore, 
a clear variation between the different homologs was 
observed, where expression of acetoacetyl-CoA synthase 
from S. glaucescens improved production fourfold com-
pared to SCIST20. Surprisingly, a decrease in production 
was observed for acetoacetyl-CoA synthase from S. afgh-
aniensis. Overexpression of KASIII enzymes from S. lac-
tacystinaeus and N. brasiliensis did not have a significant 
effect on production of farnesene.
Considering the final optical density, the growth of the 
strains expressing nphtT7SCL instead of ERG10 was clearly 
affected (Fig. S2). While SCIST15 (control, CEN.PK113-
5D background) and SCIST16 (ACC1**) reached an 
equal final OD600 of 12.4 after 72 h of cultivation, strains 
SCIST18 (erg10Δ::nphT7SCL) and SCIST20 (ACC1**, 
erg10Δ::nphT7SCL) reached a final OD600 of 5.5 and 7.2 
on average, respectively. In accordance with this, the cul-
tivation broth of strain SCIST18 and 20 still contained 5.0 
and 3.6 g/L of ethanol. On the other hand, final OD and 
ethanol concentration were almost identical when expres-
sion of nphT7SCL was enhanced using PTEF1 (SCIST39). 
This observation prompted us to investigate the growth 
kinetics in more detail. For this purpose, strains SCIST15, 
16, 18, 20 and 39 were cultivated using the BioLec-
tor to monitor growth continuously. From the recorded 
growth curves shown in Fig. 4 it can be seen that strains 
SCIST15 and 16 entered the diauxic shift after approxi-
mately 20 h of cultivation and reached stationary phase 
Fig. 3  a Replacing endogenous ERG10 in S. cerevisiae by nphT7 
from Streptomyces sp. strain CL190 in combination with ACC1** 
overexpression for production of farnesene. All strains carry plas-
mid pIST05 for expression of farnesene synthase and truncated 
HMG-CoA reductase. b Comparison of different nphT7 homologs in 
strain SCIST19 (ACC1**, erg10Δ::nphT7SCL). The homologs were 
expressed from plasmid together with farnesene synthase and trun-
cated HMG-CoA reductase. SCL—Streptomyces sp. strain CL190, 
Sg—S. glaucescens, Sa—S. afghaniensis, Sl—S. lactacystinaeus 
and Nb—N. brasiliensis. Bars represent average concentrations of 
farnesene with respect to the volume of aqueous medium of at least 
three biological replicates with standard deviation
Fig. 4  Effect of replacing endogenous ERG10 by bacterial nphT7SCL 
on growth of S. cerevisiae. Average optical density of four biological 
replicates measured online using BioLector. Indicated relevant geno-
types refer to strains: SCIST15 (control), 16, 18, 20, 39 (from top to 
bottom)
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after approximately 35 h. In contrast, for strains SCIST18 
and 20 the diauxic shift occurred after approximately 30 h 
and consumption of all carbon sources from the medium 
required up to 90 h. Especially during the second half of 
the cultivation, while the control (SCIST15) was still grow-
ing exponentially, these strains displayed significantly 
impaired growth, which could point towards transcrip-
tional regulation of ERG10 during the ethanol consumption 
phase. Strain SCIST39 (ACC1**, erg10Δ::PTEF1-nphT7SCL) 
with enhanced expression of nphT7SCL using PTEF1 dis-
played a longer lag phase, but otherwise similar growth 
in comparison to the reference. To quantify the effect of 
the ERG10 substitution by nphT7SCL the specific growth 
rates were calculated for exponential growth during each 
phase (Fig. S3), which demonstrates a clear reduction that 
can be assigned to this modification. Finally, the identical 
experiment was also performed with strains SCIST33-37 
(ACC1**, erg10Δ::nphT7SCL), which express the different 
homologs in addition to the integrated nphT7 from Strepto-
myces sp. strain CL190 (Fig. S4) to examine their effect on 
growth. In accordance with the results for final farnesene 
titers (Fig. 3b), nphT7 from S. glaucescens showed the 
most significant effect on growth, particularly during the 
ethanol consumption phase in comparison to the reference 
SCIST20 (ACC1**, erg10Δ::nphT7SCL) as stationary phase 
was reached after 60 h instead of over 100 h of cultivation.
Manipulating the pool of malonyl‑CoA 
by downregulation of fatty acid synthesis
Farnesene concentrations decreased substantially after 
replacing acetoacetyl-CoA thiolase by the respective 
acetoacetyl-CoA synthase from Streptomyces sp. strain 
CL190. Malonyl-CoA represents an important precursor 
for this pathway as well as for fatty acid synthesis and, 
therefore, its availability for the mevalonate pathway might 
be insufficient. Since overexpression of ACC1** alone did 
not improve pathway efficiency, downregulation of fatty 
acid synthase could serve as a potential strategy to redi-
rect more flux towards the mevalonate pathway. For this 
purpose, PHXT1 was used to downregulate FAS1, encoding 
the beta subunit of the fatty acid synthase in yeast, which 
utilizes acetyl-CoA and malonyl-CoA to synthesize fatty 
acyl-CoA. The hexose transporter Hxt1p was shown to 
be active in S. cerevisiae at higher glucose concentrations 
(≥1% [26], full induction at 4% [22]) and its promoter has 
previously been used to increase the production of ses-
quiterpenes by diverting flux from the FPP branch point 
[28]. For this reason, strains were cultivated in fed-batch 
mode to obtain low glucose concentrations and to activate 
downregulation of FAS1. The feeding profile was designed 
to allow for exponential growth and to keep the glucose 
concentration close to zero. With the objective to reduce 
overflow metabolism and to maintain fully respiratory con-
ditions, the respiratory quotient (RQ) was additionally used 
as a control parameter to indirectly control the concentra-
tion of glucose in the medium [32]. To utilize the avail-
able pool of malonyl-CoA more efficiently as a substrate 
for the mevalonate pathway, strain SCIST41 (ACC1**, 
erg10Δ::PTEF1-nphT7SCL, PFAS1Δ::PHXT1) was transformed 
with plasmid pIST13 carrying nphT7 from S. glaucescens, 
which showed higher efficiency compared to the one from 
Streptomyces sp. strain CL190 (Fig. 3b). Strain SCIST40 
(ACC1**, erg10Δ::PTEF1-nphT7SCL) did not contain the 
modification of FAS1 and was used as a reference. The 
two strains showed significantly different growth profiles 
during the batch phase as indicated by their CO2 profiles, 
showing that downregulation of FAS1 resulted in reduced 
CO2 formation during the glucose and ethanol phase (Fig. 
S5). During the fed-batch phase the medium was fed expo-
nentially to theoretically support a specific growth rate 
of μ = 0.08 h−1. However, both strains did not maintain 
growth at 0.08 h−1, with strain SCIST40 reaching a growth 
rate of 0.068 ± 0.003 h−1. Ethanol reached 2.3 g/L on aver-
age and the glucose concentration remained close to zero 
over 18 h (Fig. 5a). After approximately 12 h, the RQ con-
trol was activated, which was used as feedback control to 
avoid overflow metabolism, resulting in slightly oscillating 
RQ values (Fig. S6). Farnesene was produced at a yield of 
0.57 ± 0.19 mg/g glucose with final titers of 13.8 ± 4.1 mg/
Laq. On the contrary, the percentage of CO2 in the exhaust 
gas slightly decreased over time for strain SCIST43 (Fig. 
S6) and biomass concentrations stayed almost constant at 
approximately 2.2 gDCW/L (Fig. 5b). Farnesene and etha-
nol could only be detected in minor quantities. Consistent 
with these data, the glucose concentration increased, reach-
ing up to 16.4 ± 0.7 g/L. To identify changes in fatty acid 
metabolism due to downregulation of FAS1, the lipid con-
tent of the cell was analyzed at the end of the fed-batch. 
The most significant differences were observed considering 
the content of storage lipids as triacylglycerides dropped by 
88% from 31.6 ± 8.5 to 3.9 ± 0.4 mg/gDCW (Table 3). 
Besides, a clear effect was observed regarding the mem-
brane composition as phosphatidylcholine, phosphatidylin-
ositol as well as ergosterol decreased substantially. 
Discussion
A recently identified acetoacetyl-CoA synthase from 
Streptomyces sp. strain CL190, which catalyzes the con-
densation of malonyl-CoA and acetyl-CoA to generate 
acetoacetyl-CoA, has been proposed as a potential tar-
get to enhance production of acetoacetyl-CoA derived 
compounds. In this study, the encoding gene, nphT7, was 
expressed in S. cerevisiae and its effect on cell growth and 
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production of farnesene was investigated. Besides, differ-
ent homologs were compared with the objective to iden-
tify an acetoacetyl-CoA synthase with superior efficiency. 
For this purpose, nphT7SCL and the respective homologs 
from S. glaucescens, S. afghaniensis, S. lactacystinaeus 
and N. brasiliensis were expressed from plasmid together 
with genes encoding a farnesene synthase (FarnSyn) and 
a truncated version of the HMG-CoA reductase (tHMG1), 
which has been identified as a flux controlling enzyme of 
the mevalonate pathway [20]. Most importantly, production 
of farnesene did not benefit from acetoacetyl-CoA synthase 
expression in these experiments (Fig. 2a). In addition, no 
difference was observed between yeast strains expressing 
the selected homologs from other bacterial species con-
sidering the final titers of farnesene. In fact, final titers 
appeared to be slightly decreased in comparison to the 
reference (no expression of nphT7SCL, SCIST05). While 
these results could indicate insufficient activity of NphT7, 
the levels of malonyl-CoA were assumed to play a crucial 
role for this route and the overall effect of the enzyme. 
To investigate this hypothesis, the intracellular concentra-
tion of malonyl-CoA was increased by overexpression of 
ACC1** [30]. However, raising the pool of malonyl-CoA 
revealed to have a negative effect on the production of 
farnesene (Fig. 2b). Apart from this, expression of tHMG1 
was used to pull the flux towards the downstream reactions 
of the pathway and to assure efficient conversion of ace-
toacetyl-CoA. Nonetheless, higher concentrations of ace-
toacetyl-CoA may promote the thiolysis activity of the 
endogenous Erg10, ultimately generating a futile cycle 
between acetyl-, malonyl- and acetoacetyl-CoA. There-
fore, we aimed at blocking thiolysis activity of acetoacetyl-
CoA thiolase by replacing ERG10 with nphT7 from Strep-
tomyces sp. strain CL190. This step is critical as deletion 
of ERG10 was shown to result in mevalonate auxotrophy 
[10]. Although nphT7SCL was able to complement the loss 
of ERG10, significant changes were observed considering 
growth and product formation. Strains with nphT7SCL inte-
grations displayed slower growth, particularly during the 
ethanol consumption phase (Fig. 4). Similarly, production 
of farnesene was strongly impaired as final titers decreased 
by 92% (SCIST15 vs. SCIST18, Fig. 3a), illustrating that 
the availability of acetoacetyl-CoA was severely impaired 
when the endogenous thiolase was lost. To enhance the flux 
via the malonyl-CoA bypass, this strategy was again com-
bined with overexpression of ACC1**. However, consistent 
with previous results, increasing the level of malonyl-CoA 
did not improve farnesene production. Altogether, these 
results illustrate that the bypass via malonyl-CoA is sig-
nificantly less efficient compared to the endogenous path-
way. Clearly, production of FPP is not only extended by an 
additional reaction in the altered pathway, the demand of 
Fig. 5  Downregulation of FAS1 using PHXT1 in S. cerevisiae with 
ACC1** overexpression and erg10Δ::PTEF1-nphT7SCL substitution 
from Streptomyces sp. strain CL190 for improved utilization of mal-
onyl-CoA as substrate for the mevalonate pathway. a Strain SCIST40 
without FAS1 downregulation and b strain SCIST43 with FAS1 down-
regulation. In addition to the integrated copy, both strains express 
nphT7 from S. glaucescens from plasmid pIST13. Data represents 
average values of four biological replicates with standard deviation 
obtained during the fed-batch phase. Diamonds biomass, squares glu-
cose, circles ethanol and triangles farnesene
Table 3  Lipid quantification 
in strains SCIST40 and 43 after 
15 h of exponential feeding
Data represent average values in mg/gDCW of four biological replicates ± standard deviation
−FAS1 downregulation (SCIST40) +FAS1 downregulation (SCIST43)
Triacylglycerol 31.56 ± 8.49 3.89 ± 0.41
Phosphatidylinositol 2.47 ± 0.50 0.46 ± 0.07
Phosphatidylcholine 2.33 ± 0.45 0.80 ± 0.10
Ergosterol 3.43 ± 0.60 1.72 ± 0.21
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ATP also increases from 9 to 12 mol of ATP per mole of 
FPP due to the conversion of acetyl-CoA to malonyl-CoA, 
which makes the pathway disadvantageous from an ener-
getic perspective. However, sufficient flux towards mal-
onyl-CoA is essential to maintain growth as it represents 
an essential building block in lipid metabolism. Instead 
of the greater ATP cost of the pathway, insufficient effi-
ciency of the acetoacetyl-CoA synthase could cause these 
detrimental effects. To further investigate this hypothesis, 
two approaches were pursued to enhance expression of 
nphT7SCL. First, a different promoter (PTEF1) was used for 
expression instead of the ERG10 promoter, which resulted 
in an almost fourfold increase (Fig. 3a, SCIST20 vs. 
SCIST39). Although data on the activity of the promoters 
in these conditions is not available, transcriptional regula-
tion of ERG10 could be impaired when PTEF1 is used for 
expression [7]. Second, the copy number was increased by 
expressing the gene from a multi-copy plasmid in addition 
to the integrated copy (also using a strong promoter). In 
this case, a more than twofold increase in final farnesene 
titers was detected (Fig. 3b, SCIST20 vs. SCIST33). Sur-
prisingly, a difference between the selected homologs 
became apparent, clearly indicating superior efficiency of 
nphT7 from S. glaucescens, leading to a fourfold increase 
(Fig. 3b, SCIST20 vs. SCIST34). Similarly, Lan and Liao 
[14] investigated the in vitro activity of different NphT7 
homologs, e.g. from Streptomyces coelicolor, Streptomy-
ces avermitilis and Pseudomonas aeruginosa, but found 
NphT7 from Streptomyces sp. strain CL190 to be the most 
active. Besides farnesene production, also the growth kinet-
ics could be improved by enhancing the expression or 
increasing the copy number. Except for the extended lag 
phase, SCIST39 (PTEF1-ACC1**, erg10Δ::PTEF1-nphT7SCL) 
almost showed the same growth profile as SCIST15 (con-
trol) (Fig. 4). Similarly, SCIST34, which expresses nphT7 
from S. glaucescens from plasmid showed the most signifi-
cant improvement in growth compared with SCIST20 (Fig. 
S4). Based on these results, we conclude that acetoacetyl-
CoA synthase activity is not sufficient to enable high fluxes 
through the mevalonate pathway. This could also partially 
explain why no improvement was attained when levels of 
malonyl-CoA were elevated by overexpression of ACC1**. 
On the other hand, malonyl-CoA is the key precursor for 
lipid synthesis and enhancing its concentration may divert 
the flux away from the mevalonate pathway. Therefore, 
downregulation of FAS1 aimed at increasing the avail-
ability of this substrate, which might otherwise be lost to 
competing reactions. This approach was recently used to 
significantly improve production of 3-HP, which is directly 
derived from malonyl-CoA [5]. Previous studies have 
shown that the activity of the HXT1 promoter amounts to 
less than half of the FAS1 promoter at glucose concentra-
tions of 2% [12], which was clearly visible during the batch 
phase (Fig. S5) and as anticipated, even more pronounced 
during the fed-batch phase (Fig. 5b, Fig. S6). Efficient 
downregulation of FAS1 was also evident by the signifi-
cant reduction of storage lipids (TAGs) and phospholipids 
(Table 3), which suggests increased availability of malonyl-
CoA in connection with ACC1** overexpression. However, 
instead of using the pool of malonyl-CoA for the meva-
lonate pathway to a greater extend, the metabolic activity 
of the strain was significantly reduced as seen by the CO2 
profile as well as the production of farnesene and ethanol 
(Fig. 5b, Fig. S6). While these results again point towards 
the low efficiency of NphT7, this phenotype could poten-
tially arise from a build-up of malonyl-CoA to toxic levels, 
a mechanism, which has previously been studied in human 
cancer cells [23]. Here, inhibition of the fatty acid synthase 
was shown to be severely toxic, which was accompanied 
by a substantial increase in the intracellular levels of mal-
onyl-CoA. Surprisingly, although starvation for fatty acids 
served as a potential explanation for these results, inhibi-
tion of the preceding reaction catalyzed by acetyl-CoA 
carboxylase did not impair the viability of the cells and 
resulted in a reduction of malonyl-CoA concentrations.
In conclusion, this study investigated utilization of 
nphT7 from Streptomyces sp. strain CL190 as a target to 
improve production of farnesene. Similar studies have been 
performed for example for the production of butanol with 
diverse outcomes. In E. coli, overexpression of the nphT7 
route was significantly less efficient for acetoacetyl-CoA 
supply compared with the atoB route [19]. Schadeweg 
et al. on the other hand could show that NphT7 supports 
production of butanol [29]. In our experiments, expres-
sion of nphT7SCL did not improve production. We could 
show that the efficiency of the enzyme represents a central 
aspect that affects the functionality of the overall pathway. 
Although nphT7SCL was able to compensate for the loss of 
ERG10, which otherwise would result in an auxotrophy 
for mevalonate, the replacement had a severe effect on cell 
growth. Laboratory evolution could be used in the future 
as a strategy to improve growth of the strain. Furthermore, 
expressing different homologs of nphT7SCL in the erg10Δ 
background allowed for identification of a superior candi-
date from S. glaucescens. To overcome disadvantageous 
properties of acetoacetyl-CoA synthase, several alterna-
tive strategies exist to improve flux through the first part 
of the pathway. Production of sesquiterpenes could be 
significantly enhanced by improving acetyl-CoA synthe-
sis in combination with overexpression of the endogenous 
ERG10 [2]. On the other hand, acetoacetyl-CoA thiolase 
from Clostridium acetobutylicum, which has been previ-
ously used for production of farnesene [27], was shown to 
have a significantly higher in vitro activity compared to the 
thiolase from S. cerevisiae [29]. Besides, further genetic 
modifications might be required to pull more flux through 
921J Ind Microbiol Biotechnol (2017) 44:911–922 
1 3
the mevalonate pathway and particularly to redirect flux 
from the FPP branch point towards farnesene.
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